Dr. Nicaise NdembiDr. Nicaise Ndembi

Coordinator, Scientific Committee

Dr. Ndembi is currently serving as the Director of Laboratory Research with the Institute of Human Virology Nigeria (IHVN) and Chief Science Advisor at the Africa Centers for Disease Control and Prevention (Africa CDC).

Additionally, in this role, Dr. Ndembi supports HIV and AIDS, TB, and Malaria treatment and research programs. With a structure to develop and maintain linkages with local, state and federal organizations, IHVN supports the Government of Nigeria’s Health Sector Strategic Plans through key implementation partnerships with the Centers for Disease Control and Prevention (CDC) and the Global Fund.

Dr. Ndembi postdoctoral research in 2005 on viral fitness and HIV drug resistance at Case Western Reserve led him back to Africa to Head the Virology Laboratory MRC/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit where he supported a cluster-randomized equivalence trial funded by CDC and the Medical Research Council and subsequently a multicountry randomized controlled trial on Development of Antiretroviral Therapy in Africa to study extensive HIV resistance employing molecular techniques. In 2013, Nicaise became Director of Laboratory Research with the Institute of Human Virology Nigeria (IHVN).

Dr. Ndembi has served on several scientific advisory panels and continues to serve as an advisor on HIV drug resistance and control policy to Nigeria’s Federal Ministry of Health. He is a member of the PharmAccess Technical Advisory board for the Pan-African Study for Evaluation of Resistance (PASER) in Africa (Lancet Infectious Diseases 2012), WHO Resistance Network Technical Working Group and Guidelines Development Group Member (Lancet 2012). He has authored/co-authored more than 130 publications in peer-reviewed journals. He is the Editor in Chief for the Africa CDC Journal of Public Health in Africa, AIDS Research and Therapy, Associate Editor for Frontiers in Public Health and Section Editor for the African Journal of Laboratory Medicine.

Dr. Ndembi is a member of numerous international review boards and a principal investigator and co-investigator for the US National Health Institute (NIH) grants. Dr. Ndembi main research interest includes HIV vaccine research especially understanding protective immune responses, genomics epidemiology, microbiome, Emerging and Re-Emerging Infectious Diseases, HIV diversity, and resistance to Antiretroviral Therapy (ART).

He is the Scientific Committee lead of the Nigeria COVID-19 Research Consortium (NCRC), a member of the Presidential Task Force on COVID-19 response in Nigeria (PFTCOVID-19 – Laboratory) and Africa Task Force for coronavirus (AFTCOR), Africa CDC, AU.

Dr. Ndembi is a graduate of Kanazawa University School of Medicine, Department of Viral Infection and International Public Health. He is Adjunct Associate Professor, Division of Epidemiology and Prevention at the IHV, University of Maryland School of Medicine, US and Research Professor, Global Affairs Section, Kanazawa University, Japan.